Common Contracts

INTERLEUKIN GENETICS, INC.

Interleukin Genetics Inc • November 18th, 2015 • In vitro & in vivo diagnostic substances • Delaware

• Company
  Interleukin Genetics Inc
• Filed
  November 18th, 2015
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Delaware

As of April 6, 2015 (the “Grant Date”), Interleukin Genetics, Inc. (the “Company”), a Delaware corporation, grants to Mark Carbeau (the “Participant”) the right and option (the “Option”) to purchase up to 11,622,279 shares of the common stock, $.001 par value per share, of the Company (the “Shares”) at a purchase price of $0.1525 per share (the “Purchase Price”) on the terms and conditions and subject to all the limitations set forth in this Agreement. For the purpose of this Agreement, the initial vesting date shall be April 6, 2016 (“Initial Vesting Date”).

NON-QUALIFIED STOCK OPTION AGREEMENT 250,000 SHARES OF COMMON STOCK,

Synta Pharmaceuticals Corp • November 6th, 2014 • Pharmaceutical preparations • Delaware

• Company
  Synta Pharmaceuticals Corp
• Filed
  November 6th, 2014
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

As of September 2, 2014 (the “Grant Date”), Synta Pharmaceuticals Corp. (the “Company”), a Delaware corporation, grants to Anne C. Whitaker (the “Participant”) the right and option (the “Option”) to purchase up to 250,000 shares of the common stock, $.0001 par value per share, of the Company (the “Shares”) at a purchase price of $4.00 per share (the “Purchase Price”) on the terms and conditions and subject to all the limitations set forth in this Agreement. For the purpose of this Agreement, the initial vesting date shall be September 2, 2015 (“Initial Vesting Date”).